Insiders · Profile

Peetz Christopher

CHIEF EXECUTIVE OFFICER at Mirum Pharmaceuticals. Filing since 6 Sep 2019. CIK 0001614740

Company
Date
Role
Action
Shares
Amount
Of holding
1 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
30,000
$2.96M
13.4%
10 Aug 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
20,000
$1.98M
9.3%
6 Jul 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
20,000
$2.45M
9.3%
1 Jun 2026
CHIEF EXECUTIVE OFFICER
Sold on a plan
30,000
$2.88M
13.4%
16 Mar 2026
CHIEF EXECUTIVE OFFICER
Sold at will
40,985
$3.77M
17.4%
2 Feb 2026
CHIEF EXECUTIVE OFFICER
Sold at will
9,108
$940.89K
5.4%
26 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold at will
6,831
$657.09K
3.9%
22 Jan 2026
CHIEF EXECUTIVE OFFICER
Sold at will
7,098
$662.42K
4.2%
11 Aug 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
40,000
$2.48M
22.4%
7 Aug 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
40,000
$2.21M
22.4%
17 Mar 2025
CHIEF EXECUTIVE OFFICER
Sold at will
27,279
$1.21M
16.4%
3 Mar 2025
CHIEF EXECUTIVE OFFICER
Sold on a plan
40,000
$1.88M
25.7%
3 Feb 2025
CHIEF EXECUTIVE OFFICER
Sold at will
9,102
$438.92K
7.3%
24 Jan 2025
CHIEF EXECUTIVE OFFICER
Sold at will
6,837
$327.66K
5.2%
7 Jan 2025
CHIEF EXECUTIVE OFFICER
Sold at will
7,489
$320.64K
5.9%
2 Feb 2024
CHIEF EXECUTIVE OFFICER
Sold at will
6,013
$157.49K
5.5%
8 Jan 2024
PRESIDENT AND CEO
Sold at will
5,209
$146.03K
4.5%
3 Jul 2023
President and CEO
Sold at will
5,498
$141.01K
4.6%
9 Jan 2023
CHIEF EXECUTIVE OFFICER
Sold at will
5,159
$106.39K
5.3%
24 Nov 2021
President and CEO
Bought
7,000
$100.80K
33.3%
1 Oct 2021
President and CEO
Sold, plan not stated
3,672
$70.71K
14.9%
23 Dec 2020
President and CEO
Bought
5,000
$93.48K
2.5%
9 Sep 2019
President and CEO
Bought
4,320
$48.13K
2.2%
6 Sep 2019
President and CEO
Bought
4,750
$51.81K
2.5%
24 decisions on file.